Jasper Therapeutics, Inc.
JSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$71,269 | -$64,465 | -$37,685 | -$30,637 |
| Dep. & Amort. | $1,373 | $1,108 | $1,310 | $377 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,619 | $5,211 | $0 | $1,048 |
| Change in WC | $173 | $5,103 | -$649 | $1,621 |
| Other Non-Cash | $502 | $976 | -$8,834 | -$6,087 |
| Operating Cash Flow | -$62,602 | -$52,067 | -$45,858 | -$33,678 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$552 | -$267 | -$576 | -$2,428 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $20 | $0 | $0 | $0 |
| Investing Cash Flow | -$532 | -$267 | -$576 | -$2,428 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $47,195 | $101,479 | $55 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $689 | -$508 | $0 | $100,969 |
| Financing Cash Flow | $47,884 | $100,971 | $55 | $100,969 |
| Forex Effect | $0 | $0 | -$72 | $0 |
| Net Chg. in Cash | -$15,250 | $48,637 | -$46,451 | $64,863 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $87,304 | $38,667 | $84,701 | $20,183 |
| End Cash | $72,054 | $87,304 | $38,250 | $85,046 |
| Free Cash Flow | -$63,154 | -$52,334 | -$46,434 | -$36,106 |